SYNTHESIS OF SOME 2-ARYL-1,2,4-TRIAZOLO[1,5-C][1,3]BENZOXAZIN-5-ONES AS TOOLS TO DEFINE THE ESSENTIAL PHARMACOPHORIC DESCRIPTORS OF A BENZODIAZEPINE RECEPTOR-LIGAND

被引:24
作者
CATARZI, D
CECCHI, L
COLOTTA, V
FILACCHIONI, G
VARANO, F
MARTINI, C
GIUSTI, L
LUCACCHINI, A
机构
[1] UNIV FLORENCE,DIPARTIMENTO SCI FARMACEUT,I-50121 FLORENCE,ITALY
[2] UNIV PISA,IST POLICATTEDRA DISCIPLINE BIOL,I-56100 PISA,ITALY
关键词
D O I
10.1021/jm00012a020
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and benzodiazepine receptor (BZR) affinity of some 1,2,4-triazolo[1,5-c][1,3]benzoxazin-5-ones, 2-22, are reported. Compounds 2-22 are devoid of the proton donor group, which according to a BZR schematic model was one of the pharmacophoric descriptors for receptor-ligand interaction. The binding data show that 2-(2-fluorophenyl)-9-chloro-1,2,4-triazolo[1,5-c][1,3]benzoxazin-5-one (12) and some other compounds display nanomolar BZR affinity, indicating that the hydrogen donor group is not essential for the anchoring of 6,6,5-tricyclic systems to the BZR but only affects the potency of a ligand.
引用
收藏
页码:2196 / 2201
页数:6
相关论文
共 29 条
[1]  
Villar H.O., Davies M.F., Loew G.H., Maguire P.A., Molecular models for recognition and activation at benzodiazepine receptor: a review, Life Sci., 48, pp. 593-602, (1991)
[2]  
Crippen G.M., Distance geometry analysis of the benzodiazepine binding site, Mol. Pharmacol., 22, pp. 11-19, (1982)
[3]  
Fryer R.I., Ligand interactions at the benzodiazepine receptor, Comprehensive Medicinal Chemistry, 3, pp. 539-566, (1989)
[4]  
Fryer R.I., Gu Z.-Q., Wang C.G., Synthesis of novel substituted 4H-imidazo[1, 5-a][1, 4]benzodiazepines, J. Heterocycl. Chem., 28, pp. 1661-1669, (1991)
[5]  
Codding P.W., Muir A.K.S., Molecular structure of Ro 15-1788 and a model for binding of benzodiazepine receptor ligands, Mol. Pharmacol., 28, pp. 178-184, (1985)
[6]  
Allen M.S., Hagen T.J., Trudell M.L., Codding P.W., Skolnick P., Cook J.M., Synthesis of novel 3-substituted β-carbolines as benzodiazepine receptor ligands: probing the benzodiazepine receptor pharmacophore, J. Med. Chem., 31, pp. 1854-1861, (1988)
[7]  
Borea P.A., Gilli G., Bertolasi V., Ferretti V., Stereochemical features controlling binding and intrinsic activity properties of benzodiazepine-receptor ligands, Mol. Pharmacol., 31, pp. 334-344, (1987)
[8]  
Tebib S., Bourguignon J.J., Wermuth C.G., The active analog approach applied to the pharmacophore identification of benzodiazepine receptor ligands, J. Comput-Aided Mol. Des, 1, pp. 153-170, (1987)
[9]  
Villar H.O., Uyeno E.T., Toll L., Polgar W., Davies M.F., Loew G.H., Molecular determination of benzodiazepine receptor affinities and anticonvulsant activities, Mol. Pharmacol., 36, pp. 586-600, (1989)
[10]  
Trudell M.L., Lifer S.L., Tan Y.-C., Martin M.J., Deng L., Skolnick P., Cook J.M., Synthesis of substituted 7, 12- dihydropyrido[3, 2-b: 5, 4-b’]diindoles: rigid planar benzodiazepine receptor ligands with inverse agonist/antagonist properties, J. Med. Chem., 33, pp. 2412-2420, (1990)